Charles River Laboratories International financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

찰스 리버 래브러토리스 인터내셔널NYSE:CRL · New York Stock Exchange · Healthcare

$290.19+1.17%

2026-10-02 close

Charles River Laboratories International's published financial data is dated 2026-10-04. 2024 revenue was $4.05B. 2024 operating profit was $227M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy